For media enquiries or more information about research at the Djavad Mowafaghian Centre for Brain Health, please contact Emily Wight, Communications Manager.

To keep in touch with the Centre and up-to-date on our research, follow us on Twitter or subscribe to Brain Matters, our monthly e-newsletter.

Heather Yong, pictured in front of the Djavad Mowafaghian Centre for Brain Health.
Heather Yong: Plotting a Path from Bench to Bedside Mar 20, 2018

Heather Yong is a Directed Studies student in the Faculty of Medicine at the University of British Columbia. She has been volunteering with the UBC MS/NMO Clinic and Research Group at the Djavad Mowafaghian Centre for Brain Health since 2013.

Canadian Open Neuroscience Platform launches with participation from DMCBH researchers Mar 15, 2018

For Canadian neuroscientists, the Canadian Open Neuroscience Platform (CONP) will make data collected through imaging, genome mapping, and other research methods accessible and easier to share with colleagues across the country, improving the odds of producing big discoveries as research data become available to more researchers.

Counselling session between two women.
Psychiatric conditions may affect disability progression in MS Mar 14, 2018

New research from Dr. Helen Tremlett’s Pharmacoepidemiology in Multiple Sclerosis Research Group suggests that for people with multiple sclerosis (MS), the presence of psychiatric comorbidities including depression, anxiety and mood disorders was associated with disability progression.

Family enjoying the sunshine with balloons.
Let the sun shine in: new research shows sun's rays may reduce MS risk Mar 7, 2018

People who live in areas where they are exposed to more of the sun's rays, specifically UV-B rays, may be less likely to develop multiple sclerosis (MS) later in life, according to a study published in today in the journal Neurology. Exposure in childhood and young adulthood may also reduce risk.

Wellington lab
Budget 2018 offers hope, opportunity for Canadian research Feb 28, 2018

Pictured: The Honourable Jody Wilson-Raybould (third from left), Minister of Justice and Member of Parliament, visits Dr. Cheryl Wellington's lab on a tour of DMCBH on October 13, 2017. Image credit: Paul Joseph.

Drs MacVicar, Winstanley, Sossi, Clark, Murphy and MP Gordie Hogg.
Member news: February 2018 Feb 26, 2018

Pictured: Dr. Brian MacVicar shows off the future home of the human brain imaging facility at the Djavad Mowafaghian Centre for Brain Health on a tour with MP Gordie Hogg and Dr. Vesna Sossi, Dr. Catharine Winstanley, Dr. Luke Clark, and UBC's Vice-President, Research & Innovation, Dr. Gail Murphy (February 21, 2018).

Hopeful mature couple.
Increases in cholinergic system activity affect those with Parkinson-linked gene mutation Feb 16, 2018

A particular gene mutation associated with an inherited form of Parkinson’s disease (PD) offers new clues that call into question a controversial theory that changes associated with PD may begin in a different area of the brain. Idiopathic PD, a spontaneous form of the disease, affects the dopamine system and is treated with replacement therapy to restore the brain’s chemical balance and alleviate physical symptoms. Other neurotransmitter systems are often involved, but it is not clear whether this occurs prior to or after the dopamine loss characteristic of PD.  

Dr. Carles Vilarino-Guell
New MS model provides hope for better understanding of disease pathology Feb 14, 2018

Until now, researchers studying multiple sclerosis (MS) in mouse models have relied on models heavily weighted towards processes secondary to an autoimmune trigger. While discoveries made through these models have informed later translational research and clinical trials to improve drug treatment for people living with MS, a lack of a model for the unique biological process by which the disease progresses in the brain has been challenging.

Teenage girls in a research lab.
MS researcher-led event encourages teenagers to choose science Feb 13, 2018

In Grade 10, fifteen- and sixteen-year-olds begin making the academic decisions that may shape their lives, opting for electives in the sciences or the arts. What they choose will influence where they plan to go to university, what they plan to study, and who they ultimately become.

Helen Tremlett receives substantial CIHR funding to study MS drugs.
A million-dollar study to evaluate MS drug safety and effectiveness Feb 5, 2018

There are more than ten different drug therapies approved in Canada to treat multiple sclerosis (MS), but what do we know about their long-term value? With a $1.2 million endorsement from CIHR, Dr. Helen Tremlett, Canada Research Chair in Neuroepidemiology and Multiple Sclerosis and her team, will determine the safety and effectiveness of commonly prescribed MS drugs.